Ma Jingyun, Wang Yachen, Liu Jing
Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University Dalian 116011 China
Stem Cell Clinical Research Center, The First Affiliated Hospital of Dalian Medical University Dalian 116011 China.
RSC Adv. 2018 Jun 19;8(39):21712-21727. doi: 10.1039/c8ra03022g. eCollection 2018 Jun 13.
Accompanied by the increasing demand for organ transplants and personalized medicine, recent years have witnessed great developments in the regeneration of tissues/organs, which has benefited from various manufacturing technologies, especially 3D bioprinting. In 3D bioprinting, according to the morphogenesis, cellular microenvironment, and biological functions of the native tissues/organs, cells and biomaterials are printed by layer-by-layer assembly to form 3D bio-functional units. However, there are still substantial differences between existing 3D printed constructs and actual tissues and organs, especially in microscale structures such as vascular networks. By manipulating controllable fluids carrying biomolecules, cells, organisms, or chemical agents, microfluidic techniques aim to integrate biological or chemical functional units into a chip. With its features of biocompatibility, flexible manipulation, and scale integration on the micro/nanoscale, microfluidics has been a tool that has enabled the generation of micro-tissues/organs with precise configurations. With the inspiration of these two technologies, there have been efforts to fabricate functional living tissues and artificial organs with complex structures a combination of 3D bioprinting and microfluidics, which may lead to unexpected effects. In this review, we discuss advances in microfluidics-assisted bioprinting in the engineering of tissues/organs and provide future perspectives for this combination in the generation of highly biomimetic tissues and organs .
随着器官移植和个性化医疗需求的不断增加,近年来组织/器官再生取得了巨大进展,这得益于各种制造技术,尤其是3D生物打印。在3D生物打印中,根据天然组织/器官的形态发生、细胞微环境和生物学功能,通过逐层组装打印细胞和生物材料,以形成3D生物功能单元。然而,现有的3D打印构建体与实际组织和器官之间仍存在很大差异,尤其是在血管网络等微观结构方面。微流控技术旨在通过操控携带生物分子、细胞、生物体或化学试剂的可控流体,将生物或化学功能单元集成到芯片中。凭借其生物相容性、灵活操控以及微/纳尺度上的规模集成等特点,微流控技术已成为一种能够生成具有精确结构的微组织/器官的工具。受这两种技术的启发,人们一直在努力通过3D生物打印和微流控技术的结合来制造具有复杂结构的功能性活组织和人造器官,这可能会产生意想不到的效果。在这篇综述中,我们讨论了微流控辅助生物打印在组织/器官工程中的进展,并为这种结合在生成高度仿生的组织和器官方面提供了未来展望。